Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
12.05.25
/
50%
€1.63
Target price
12.05.26
€3.56
Performance (%)
85.46%
End price
13.05.26
€3.03
Summary
This prediction ended on 13.05.26 with a price of €3.03. The BUY prediction by Barclays_PLC for Iovance Biotherapeutics Inc. saw massive gains of 85.46%. Barclays_PLC has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 2.168% | 2.168% | 134.453% |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.44
24.12.25
24.12.25
€8.47
24.12.26
24.12.26
54.41%
04.06.26
04.06.26
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.57
25.02.26
25.02.26
€9.33
25.02.27
25.02.27
5.47%
04.06.26
04.06.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
0.70%
15.04.26
15.04.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25